BioTissue is a pioneer in the field of Regenerative Medicine and Tissue Engineering and has developed a unique Cell Therapy Technology Platform, BioSeed®.
- Articular Cartilage: BioSeed®-C
- Bone: BioSeed®-B
- Jaw-Bone: BioSeed®-Oral Bone
- Mucosa: BioSeed®-M
- Skin: BioSeed®-S
BioSeed® implants are generated using a process called Tissue Engineering. This is done by taking a tissue biopsy from the patient, and then isolating and cultivating the patient’s own cells in a GMP-Laboratory. After obtaining a sufficient number of cells, they are seeded into BioTissue’s matrix. The resulting three-dimensional living transplant is then implanted by the surgeon into the tissue defect. BioSeed® transplants replace the missing tissue and restore their original function. They provide the cells with an ideal three-dimensional, stable environment which stimulates them to redifferentiate and thus assume their original morphology and function.
BioTissue’s proprietary three-dimensional biocompatible scaffold technology developed for its BioSeed® Cell Therapy Technology Platform also forms the basis of our New Generation state-of-the art cell-free tissue regeneration implants, such as chondrotissue®.